Cargando…

Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome

BACKGROUND: X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with Turner syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of genes on the mouse X chromosome which escape X inactivation, and thus are expressed at higher...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Alexandra M, Burgoyne, Paul S, Ojarikre, Andrew, Bauer, Julien, Sargent, Carole A, Amorim, António, Affara, Nabeel A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837040/
https://www.ncbi.nlm.nih.gov/pubmed/20122165
http://dx.doi.org/10.1186/1471-2164-11-82
_version_ 1782178766158561280
author Lopes, Alexandra M
Burgoyne, Paul S
Ojarikre, Andrew
Bauer, Julien
Sargent, Carole A
Amorim, António
Affara, Nabeel A
author_facet Lopes, Alexandra M
Burgoyne, Paul S
Ojarikre, Andrew
Bauer, Julien
Sargent, Carole A
Amorim, António
Affara, Nabeel A
author_sort Lopes, Alexandra M
collection PubMed
description BACKGROUND: X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with Turner syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of genes on the mouse X chromosome which escape X inactivation, and thus are expressed at higher levels in females, is very small. However this hypothesis has never been tested and only a small number of genes have been assayed for their X-inactivation status in the mouse. We performed a global expression analysis in four somatic tissues (brain, liver, kidney and muscle) of adult 40,XX and 39,XO mice using the Illumina Mouse WG-6 v1_1 Expression BeadChip and an extensive validation by quantitative real time PCR, in order to identify which genes are expressed from both X chromosomes. RESULTS: We identified several genes on the X chromosome which are overexpressed in XX females, including those previously reported as escaping X inactivation, as well as new candidates. However, the results obtained by microarray and qPCR were not fully concordant, illustrating the difficulty in ascertaining modest fold changes, such as those expected for genes escaping X inactivation. Remarkably, considerable variation was observed between tissues, suggesting that inactivation patterns may be tissue-dependent. Our analysis also exposed several autosomal genes involved in mitochondrial metabolism and in protein translation which are differentially expressed between XX and XO mice, revealing secondary transcriptional changes to the alteration in X chromosome dosage. CONCLUSIONS: Our results support the prediction that the mouse inactive X chromosome is largely silent, while providing a list of the genes potentially escaping X inactivation in rodents. Although the lower expression of X-linked genes in XO mice may not be relevant in the particular tissues/systems which are affected in human X chromosome monosomy, genes deregulated in XO mice are good candidates for further study in an involvement in Turner Syndrome phenotype.
format Text
id pubmed-2837040
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28370402010-03-12 Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome Lopes, Alexandra M Burgoyne, Paul S Ojarikre, Andrew Bauer, Julien Sargent, Carole A Amorim, António Affara, Nabeel A BMC Genomics Research Article BACKGROUND: X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with Turner syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of genes on the mouse X chromosome which escape X inactivation, and thus are expressed at higher levels in females, is very small. However this hypothesis has never been tested and only a small number of genes have been assayed for their X-inactivation status in the mouse. We performed a global expression analysis in four somatic tissues (brain, liver, kidney and muscle) of adult 40,XX and 39,XO mice using the Illumina Mouse WG-6 v1_1 Expression BeadChip and an extensive validation by quantitative real time PCR, in order to identify which genes are expressed from both X chromosomes. RESULTS: We identified several genes on the X chromosome which are overexpressed in XX females, including those previously reported as escaping X inactivation, as well as new candidates. However, the results obtained by microarray and qPCR were not fully concordant, illustrating the difficulty in ascertaining modest fold changes, such as those expected for genes escaping X inactivation. Remarkably, considerable variation was observed between tissues, suggesting that inactivation patterns may be tissue-dependent. Our analysis also exposed several autosomal genes involved in mitochondrial metabolism and in protein translation which are differentially expressed between XX and XO mice, revealing secondary transcriptional changes to the alteration in X chromosome dosage. CONCLUSIONS: Our results support the prediction that the mouse inactive X chromosome is largely silent, while providing a list of the genes potentially escaping X inactivation in rodents. Although the lower expression of X-linked genes in XO mice may not be relevant in the particular tissues/systems which are affected in human X chromosome monosomy, genes deregulated in XO mice are good candidates for further study in an involvement in Turner Syndrome phenotype. BioMed Central 2010-02-01 /pmc/articles/PMC2837040/ /pubmed/20122165 http://dx.doi.org/10.1186/1471-2164-11-82 Text en Copyright ©2010 Lopes et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lopes, Alexandra M
Burgoyne, Paul S
Ojarikre, Andrew
Bauer, Julien
Sargent, Carole A
Amorim, António
Affara, Nabeel A
Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title_full Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title_fullStr Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title_full_unstemmed Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title_short Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
title_sort transcriptional changes in response to x chromosome dosage in the mouse: implications for x inactivation and the molecular basis of turner syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837040/
https://www.ncbi.nlm.nih.gov/pubmed/20122165
http://dx.doi.org/10.1186/1471-2164-11-82
work_keys_str_mv AT lopesalexandram transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT burgoynepauls transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT ojarikreandrew transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT bauerjulien transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT sargentcarolea transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT amorimantonio transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome
AT affaranabeela transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome